45 studies found for:    Open Studies | "Staphylococcal Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Staphylococcal Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
Condition: Staphylococcal Infection
Interventions: Other: Placebo;   Drug: XF-73 in 4% Klucel gel;   Drug: XF-73 in 2% Klucel gel
2 Recruiting Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal Infection
Intervention: Drug: Mupirocin calcium
3 Not yet recruiting Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
Condition: Staphylococcal Infections
Intervention: Drug: Daptomycin
4 Unknown  Preoperative Nasal Swabs From Pediatric Patients
Condition: Staphylococcal Infections
Intervention: Procedure: Nose swab
5 Unknown  A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely
Condition: Staphylococcal Infections
Intervention: Drug: teicoplanin
6 Unknown  Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
Condition: Staphylococcal Infections
Intervention:
7 Recruiting Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci
Conditions: Lock Solution;   Catheter Related Blood Stream Infections;   Central Venous Catheter Infection;   Intravenous Drug Delivery Systems;   Coagulase-negative Staphylococci Infection
Interventions: Drug: Ethanol 40% + Enoxaparine 400UI/ml;   Drug: Vancomycine 5 mg/ml + Héparine 2500UI/ml
8 Recruiting Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
Conditions: Staph Aureus Colonization;   Staph Aureus Infection
Interventions: Drug: Mupirocin and Chlorhexidine;   Drug: Placebo ointment and placebo cloths
9 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin  10mg/kg/24h iv
10 Recruiting Impact of Mupirocin Decolonization on the Nasal Microbiome
Condition: Nasal Colonization With Staph Aureus
Intervention:
11 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
Conditions: Methicillin-Resistant Staphylococcus Aureus;   ESBL
Intervention:
12 Recruiting Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Condition: MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions: Drug: Vancomycin continuous infusion;   Drug: Vancomycin intermittent dosing interval
13 Unknown  Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
Conditions: Methicillin-resistant Staphylococcus Aureus;   Pneumonia, Ventilator-Associated
Intervention: Drug: Imipenem/cilastatin
14 Recruiting Retapamulin for Reducing MRSA Nasal Carriage
Condition: Methicillin-Resistant Staphylococcus Aureus
Interventions: Drug: Retapamulin;   Drug: Placebo
15 Recruiting Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin;   Drug: Placebo (Sterile Water);   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Doxycycline;   Drug: Mupirocin Nasal Ointment;   Drug: 4% chlorhexidine gluconate liquid skin cleanser
16 Recruiting Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Conditions: Bacterial Infection;   Benign Neoplasm;   Malignant Neoplasm;   Methicillin-Resistant Staphylococcus Aureus Infection;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Chlorhexidine Gluconate;   Procedure: Wound Care Management;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
17 Unknown  Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns
Condition: Staphylococcus Aureus Infection
Intervention: Other: CA-MRSA Decolonization
18 Recruiting Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
Condition: Skin Diseases, Infectious
Interventions: Drug: Tedizolid(BAY1192631);   Drug: Linezolid
19 Unknown  Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)
Condition: MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Intervention: Drug: Antibiotic Prophylaxis
20 Unknown  Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections
Condition: Methicillin-resistant Staphylococcus Aureus Infection
Intervention: Other: Preoperative MRSA screening

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years